Clinical Investigation to Assess the Effect of Betaglucan Administration in HPV Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

May 15, 2025

Study Completion Date

May 15, 2025

Conditions

HPV

Interventions

DIETARY_SUPPLEMENT

1000 mg Betaglucans (daily)

Patients in the experimental group receive betaglucans supplement in capsule form, administered orally

Trial Locations (1)

Gynaecology Department, Medical Service Ishtar, Barcelona

All Listed Sponsors

lead

Vitae Health Innovation

INDUSTRY

NCT06987396 - Clinical Investigation to Assess the Effect of Betaglucan Administration in HPV Patients | Biotech Hunter | Biotech Hunter